Organic Active Ingredients TRIZ Cases

Optimizing degree of substitution balances performance and biodegradability in cationic glucan esters.

Banana flower extract reduces hair loss by inhibiting dihydrotestosterone generation, offering a side-effect-free alternative to synthetic drugs.

Anti-CD38 antibodies treat LKB1 mutant NSCLC by activating immune responses, addressing poor conventional therapy outcomes.

A MALT1 inhibitor formulation combines fatty acids with polyethylene glycol monoesters and diesters to create stable solid dosage forms.

Selective thyroid hormone receptor beta activation reduces cholesterol while avoiding cardiovascular side effects.

Resin adsorption isolates Lactarius hatsudake polysaccharides, resolving low extraction efficiency in traditional methods.

Formula I compounds inhibit mTOR and PI3K pathways to regress skin lesions without causing inflammation or permanent hypopigmentation.

Segmenting total saponins into specific ginsenosides Rb1 and Rg1 resolves the contradiction between therapeutic reliability and adverse reactions.

Recombinant hemoglobin agents overcome tumor hypoxia resistance by delivering oxygen to sensitize cancer cells to chemotherapy.

A peptide carrier conjugated to a nucleic acid with trinucleotide repeats enables effective cell penetration.

Platelet membrane coatings enable selective adherence to damaged vasculature while eliminating foreign material exposure.

Deuterium substitution in sulfonamides enhances receptor selectivity and metabolic stability, reducing side effects while treating anxiety and depression.

Retinal organoid-derived exosomes resolve tissue origin mismatch by matching ectodermal lineage to enhance photoreceptor survival and corneal wound healing.

Disposable zinc chloride applicators deliver precise chemical doses to lumpectomy sites, eliminating radiation-induced tissue damage and secondary cancer risks.

Engineered SauCas9 with synthetic guides targets single-stranded RNA, resolving the limitation of DNA-only CRISPR systems for viral modulation.

Icilin pre-treatment activates TRPM8 channels to mitigate systemic inflammation and improve cellular viability after thermal trauma.

Cyanobacteria-based dressing eliminates pathogen bacteria while reducing waste from frequent replacements.

Compound I activates the cGMP pathway via sGC stimulation, addressing the bottleneck of ineffective RAAS inhibitors and glucose-lowering medications.

A shelf-stable supercritical CO2 fluid extracts enhanced lipidosterolic extract from Serenoa repens berries.

Outer coating layer absorbs compression stress to protect enteric coating integrity, preventing cracking of brittle acid-resistant layers without plasticizers.

Melatonin injection reduces somatic cell scores by 63.54% while increasing protein and lactose content to improve milk quality.

Tetrahydropyrrolopyrazine carboxamide derivatives inhibit beta-secretase activity to block amyloid beta peptide production.

Triacetyl-3-hydroxyl phenyl adenosine resolves statin-induced myalgia by boosting nitric oxide production without triggering adverse reactions.

Ginsenoside Rk1 analogs inhibit vascular endothelial cell apoptosis and actin stress fiber formation to maintain barrier integrity.

Des-acyl ghrelin analogs reduce tumor size and metastasis while sparing normal cells from severe side effects.

An orodispersible effervescent tablet dissolves in saliva to create a foamy carrier that adheres to the esophageal mucosa.

Photochemically caged ceramide-1-phosphate derivatives bypass cytotoxic solvent artifacts to deliver active lipids into cells via light-triggered uncaging.

Simultaneous eIF5A and Notch inhibition enriches regulatory T cells to protect pancreatic beta-cells from immune destruction in Type 1 diabetes.

BCMA-targeting antibody drug conjugates deliver cytotoxic agents via endocytosis to eliminate multiple myeloma cells while sparing healthy tissue.

A crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid combined with an organic base having a pKa value from 6 to 11.

Combines DYRK1A inhibition, GLP1R agonism, and immunomodulation to reverse beta-cell loss caused by autoimmune destruction.

Formula I compounds target Mcl-1 to treat cancers where this anti-apoptotic protein drives disease progression.

Superconducting magnets stabilize fields, enabling portable NMR analysis despite high equipment costs.

Steroidal nitrone F2 counters ischemia-reperfusion injury by preemptively trapping radicals and enhancing SOD1 expression to preserve neuronal structure.

Incorporating reducing agents during synthesis removes furfural impurities from glycosyl hesperetin, eliminating bitter tastes and coloration issues.

Triazolothienopyrimidine compounds inhibit UT-B urea transporters, resolving the bottleneck of inadequate renal clearance in fluid overload.

3',5'-Cyclic phosphoramidate prodrugs overcome limited bioavailability and toxicity of existing treatments to treat hepatitis C virus.

Combining TTFields with thioredoxin reductase inhibitors disrupts antioxidant defenses in cancer cells.

Selective PPARγ binding reduces axial elongation without triggering photophobia or allergic conjunctivitis.

Heterocyclic alkynyl benzene compounds inhibit tumor cell proliferation through targeted molecular binding mechanisms.

Diazepinone derivatives resolve acid instability and poor bioavailability by modifying sugar moieties and ring structures to enhance therapeutic activity.

CRISPR-Cas9 editing of CD34+ hematopoietic stem cells down-regulates BCL11A to increase fetal hemoglobin, eliminating iron overload from transfusions.

A medical injector uses an energy storage member to extend a needle exactly 7 to 8 millimeters for precise infant dosing.

Uncoated microtablets combine HPMC and magnesium stearate to achieve sustained release, avoiding aging issues linked to ethylcellulose coatings.

Benzenetricarboxylic acid inhibits the CIC transporter to disrupt citrate export and tumor proliferation.